<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body> <br /> Kei1: Novel Subunit Inositolphosphorylceramide <br /> Synthase, Essential Enzyme Activity Golgi <br /> Localization <br />  <br />  <br /> Fungal sphingolipids inositol-phosphate head groups, essential viability cells. head <br /> groups added inositol phosphorylceramide (IPC) synthase, AUR1 thought encode enzyme.  essential protein encoded KEI1 novel subunit IPC synthase Saccharomyces cerevisiae. Kei1 localized medial-Golgi Kei1 cleaved Kex2, late Golgi processing endopeptidase;  recycles medial- late Golgi compartments. growth defect kei1-1, temperature- <br /> sensitive mutant, effectively suppressed overexpression AUR1, Aur1 Kei1 proteins form complex vivo. kei1-1 mutant hypersensitive aureobasidin  specific inhibitor IPC synthesis, IPC synthase <br /> activity mutant membranes thermolabile. Aur1 missorted vacuole kei1-1 cells. <span id='am-86' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-87' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-88' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-89' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-90' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-91' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-92' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>amino acid</span> substitution kei1-1 causes release Kei1 immunoprecipitation Aur1 Aur1 Kei1 hardly detectable IPC synthase activity. results, conclude Kei1 essential activity Golgi localization IPC synthase. <br />  <br />  <br /> INTRODUCTION                                                           suggested certain proteins assembled <span id='am-37' about='obo:IMR_0001362' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-38' property="rdfs:label" content="lipid" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasDbXref" content="CHEBI:25054" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:id" content="IMR:0001362" datatype="xsd:string"></span><span id='am-42' property="obo:IAO_0000115" content="Organic molecule that is insoluble in water but tends to dissolve in nonpolar organic solvent." datatype="xsd:string"></span>lipid</span> <br />                                                                        rafts fulfill specific essential functions signal budding yeast Saccharomyces cerevisiae, unicellular eu-          transduction (Simons Toomre, 2000; Allen et al., 2007). <br /> karyote widely used model organism cell biology,           existence lipid raft controversial (Munro, 2003), major types membrane lipids. abundant                sphingolipids important interesting irrespective glycerophospholipids glycerol backbones.             lipid rafts really exist. sterols sphingolipids. Ergosterol specific          S. cerevisiae, sphingolipids composed inositol- <br /> fungi corresponds <span id='am-103' about='obo:IMR_0200486' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-104' property="rdfs:label" content="Cholesterol" datatype="xsd:string"></span><span id='am-105' property="oboInOwl:id" content="IMR:0200486" datatype="xsd:string"></span><span id='am-106' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-107' property="oboInOwl:hasDbXref" content="KEGG:C00187" datatype="xsd:string"></span>cholesterol</span> mammals (Holthuis              phosphorylceramide (IPC) mannosylated deriva- <br /> et al., 2001). Sphingolipids phospholipids derived            tives,  mannose inositolphosphorylceramide (MIPC) <br /> ceramides, yeast sphingolipids characterized            mannose di(inositolphosphoryl)<span id='am-108' about='obo:IMR_0100177' typeof='obo:IMR_0100022 owl:Thing obo:IMR_0000947 obo:IMR_0001359 obo:IMR_0000001 obo:IMR_0001362'><span id='am-109' property="rdfs:label" content="ceramide" datatype="xsd:string"></span><span id='am-110' property="oboInOwl:hasExactSynonym" content="C2-ceramide" datatype="xsd:string"></span><span id='am-111' property="oboInOwl:hasExactSynonym" content="cer" datatype="xsd:string"></span><span id='am-112' property="oboInOwl:id" content="IMR:0100177" datatype="xsd:string"></span><span id='am-113' property="oboInOwl:hasExactSynonym" content="N-Acylsphingosine" datatype="xsd:string"></span><span id='am-114' property="oboInOwl:hasDbXref" content="KEGG:C00195" datatype="xsd:string"></span><span id='am-115' property="rdfs:label" content="N-Acylsphingosine" datatype="xsd:string"></span><span id='am-116' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-117' property="rdfs:label" content="cer" datatype="xsd:string"></span><span id='am-118' property="rdfs:label" content="C2-ceramide" datatype="xsd:string"></span>ceramide</span> [M(IP)2C] <br /> modification inositol-phosphate (IP). composition             (Figure 1). types ceramide backbones membrane lipids changes secretory path-              different positions number hydroxide groups way S. cerevisiae; e.g., sphingolipids ergosterol           IP-containing sphingolipids (Funato et al., 2002). novo abundant plasma membrane mem-                synthesis ceramide carried ceramide synthase <br /> branes (Hechtberger et al., 1994). deficiency sphingo-          composed Lag1, Lac1, Lip1 (Guillas et al., 2001; <br /> lipid biosynthesis results instability subset           Schorling et al., 2001; Vallee Riezman, 2005).  <br /> proteins localized plasma membrane (Lauwers et al.,             version ceramide IPC catalyzed IPC synthase 2007). proposed sphingolipids ergosterols form          transfers IP <span id='am-43' about='obo:IMR_0001651' typeof='owl:Thing obo:IMR_0001650 obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-44' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-45' property="rdfs:label" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasExactSynonym" content="MPI" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasExactSynonym" content="phosphoinositide" datatype="xsd:string"></span><span id='am-48' property="rdfs:label" content="phosphoinositide" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasDbXref" content="KEGG:C00626" datatype="xsd:string"></span><span id='am-50' property="rdfs:label" content="MPI" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:id" content="IMR:0001651" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasExactSynonym" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasExactSynonym" content="monophosphoinositide" datatype="xsd:string"></span><span id='am-54' property="rdfs:label" content="phosphatidylinositol" datatype="xsd:string"></span><span id='am-55' property="rdfs:label" content="monophosphoinositide" datatype="xsd:string"></span>phosphatidylinositol</span> ceramide. AUR1 specific domains called &#226;&#8364;&#339;lipid rafts&#226;&#8364;&#65533; distinct           essential gene responsible enzymatic activity <br /> <span id='am-6' about='obo:IMR_0001384' typeof='owl:Thing obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001362'><span id='am-7' property="oboInOwl:id" content="IMR:0001384" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="glycerophospholipid" datatype="xsd:string"></span>glycerophospholipid</span>-rich regions structurally                 (Nagiec et al., 1997; Dickson Lester, 1999; Levine et al., <br /> functionally plasma membrane (Edidin, 2003).              2000; Funato et al., 2002). Aur1 localized medial- <br />                                                                        Golgi compartment, indicating modifications <span id='am-119' about='obo:IMR_0100177' typeof='obo:IMR_0100022 owl:Thing obo:IMR_0000947 obo:IMR_0001359 obo:IMR_0000001 obo:IMR_0001362'><span id='am-120' property="rdfs:label" content="N-Acylsphingosine" datatype="xsd:string"></span><span id='am-121' property="oboInOwl:hasExactSynonym" content="cer" datatype="xsd:string"></span><span id='am-122' property="rdfs:label" content="ceramide" datatype="xsd:string"></span><span id='am-123' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-124' property="oboInOwl:hasExactSynonym" content="C2-ceramide" datatype="xsd:string"></span><span id='am-125' property="rdfs:label" content="cer" datatype="xsd:string"></span><span id='am-126' property="oboInOwl:hasExactSynonym" content="N-Acylsphingosine" datatype="xsd:string"></span><span id='am-127' property="oboInOwl:id" content="IMR:0100177" datatype="xsd:string"></span><span id='am-128' property="oboInOwl:hasDbXref" content="KEGG:C00195" datatype="xsd:string"></span><span id='am-129' property="rdfs:label" content="C2-ceramide" datatype="xsd:string"></span>cer</span>- <br />                                                                        amide occur transported Golgi (Levine et al., article published online ahead print MBC Press       2000). Conversion IPC MIPC suggested exe- <br /> (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E09 &#226;&#8364;&#8220; 03&#226;&#8364;&#8220; 0235)        cuted Csg1&#226;&#8364;&#8220;Csg2 Csg1&#226;&#8364;&#8220;Csh1 complex (Uemura et September 2, 2009.                                                  al., 2003), subsequent conversion MIPC M(IP)2C * Present address: Faculty Life Sciences, University Manches-    catalyzed Ipt1 (Dickson et al., 1997; Uemura et al., 2003). <br /> ter, Michael Smith Building, Oxford Road, Manchester M13           pathway ceramides change complex <br /> 9PT, United Kingdom.                                                   sphingolipids, step, e., conversion ceramide <br /> Address correspondence  Koji Yoda (asdfg@mail.ecc.u-tokyo.ac.jp).   IPC, essential viability cell.                                                                        thought accumulation ceramides Abbreviations used: CHAPS, 3-[(3-cholamidopropyl)dimethylammo- <br /> nio]propanesulfonate; ER, endoplasmic reticulum; <span id='am-10' about='obo:IMR_0001357' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-11' property="oboInOwl:hasDbXref" content="KEGG:C00035" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasAlternativeId" content="IMR:0200191" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:id" content="IMR:0001357" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="GDP" datatype="xsd:string"></span>GDP</span>, <span id='am-68' about='obo:IMR_0200445' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-69' property="rdfs:label" content="guanosine" datatype="xsd:string"></span><span id='am-70' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:id" content="IMR:0200445" datatype="xsd:string"></span><span id='am-72' property="oboInOwl:hasDbXref" content="KEGG:C00387" datatype="xsd:string"></span>guanosine</span> <br />                                                                        loss sphingolipids exert fatal effects yeast cells, diphosphate; GFP, green fluorescent protein; GST, <span id='am-56' about='obo:IMR_0100173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001700'><span id='am-57' property="oboInOwl:hasExactSynonym" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-58' property="obo:IAO_0000115" content="A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides." datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasDbXref" content="KEGG:C00051" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasExactSynonym" content="L-Glutathione" datatype="xsd:string"></span><span id='am-61' property="rdfs:label" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-62' property="rdfs:label" content="Reduced glutathione" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:id" content="IMR:0100173" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-65' property="rdfs:label" content="L-Glutathione" datatype="xsd:string"></span><span id='am-66' property="rdfs:label" content="glutathione" datatype="xsd:string"></span><span id='am-67' property="oboInOwl:hasExactSynonym" content="Reduced glutathione" datatype="xsd:string"></span>glutathione</span> trans-   obvious conversion ceramide IPC strin- <br /> ferase; HA, hemagglutinin; IPC, inositolphosphorylceramide; MIPC,      gently regulated. understand regulation IPC syn- <br /> mannose inositolphosphorylceramide; M(IP)2C, mannose di(inositol-      thesis, detailed characterization enzyme responsible phosphoryl)ceramide; TLC, layer chromatography.                   crucial. <br />  <br /> 4444                                                                                    &#194;&#169; 2009 American Society Cell Biology <br />                                                                                                          Novel Subunit Yeast IPC Synthase <br />  <br />  <br />                                                                      product YDR367w novel component                                                                      IPC synthase. interacts Aur1 vivo, essential                                                                      enzymatic activity transfers IP ceramide,                                                                      involved localization IPC synthase                                                                      medial-Golgi. undergoes cleavage                                                                      Kex2, late Golgi endoprotease.  desig- <br />                                                                      nated YDR367w Kex2-cleavable protein Essential IPC <br />                                                                      synthesis 1 (KEI1). <br />  <br />  <br />                                                                      MATERIALS METHODS <br />                                                                      Strains, Plasmids, Media, Reagents <br />                                                                      S. cerevisiae plasmids used study listed Table 1 2, <br />                                                                      respectively. construction strains plasmids described                                                                      Supplemental Data. <br />                                                                        Yeast cells grown YPD medium (1% Bacto yeast extract [BD <br />                                                                      Biosciences, Franklin Lakes, NJ], 2% Bacto peptone [BD Biosciences], 2% <br />                                                                      glucose] SD medium [0.17% yeast nitrogen base amino acids [BD <br />                                                                      Biosciences], 0.5% ammonium sulfate, 2% glucose, appropriate supple- <br />                                                                      ments) 30&#194;&#176;C unless temperatures indicated. YPD used                                                                      growth media unless specified. Solid media 1.5% <br />                                                                      agar. micrograms milliliter histidine, tryptophan,                                                                      <span id='am-98' about='obo:IMR_0200234' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-99' property="oboInOwl:id" content="IMR:0200234" datatype="xsd:string"></span><span id='am-100' property="rdfs:label" content="Uracil" datatype="xsd:string"></span><span id='am-101' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-102' property="oboInOwl:hasDbXref" content="KEGG:C00106" datatype="xsd:string"></span>uracil</span>, 0.1% 5-fluoroorotic acid (Sigma-Aldrich, St. Louis, MO)                                                                      added SD make 5-fluoroorotic acid (5-FOA) plates Ura3&#226;&#171;&#185; coun- <br />                                                                      terselection. micrograms milliliter phloxine B (Sigma-Aldrich, St. <br />                                                                      Louis, MO) added YPD make phloxine plates (Tsukada Oh- <br />                                                                      sumi, 1993) selection temperature-sensitive mutants. Aureobasidin <br />                                                                      purchased Takara Bio (Shiga, Japan). Escherichia coli DH5&#226;&#65533;&#163; (F&#226;&#171;&#186;, <br />                                                                      supE44 &#226;&#338;&#172;lacU169 &#226;&#65533;&#190;80lacZ&#226;&#338;&#172;M15 hsdR17 recA1 endA1 gyrA96 thi-1 relA1)                                                                      used plasmid propagation. E. coli grown Luria-Bertani (LB) <br />                                                                      medium (1% Bacto tryptone [BD Biosciences], 0.5% Bacto yeast extract [BD <br />                                                                      Biosciences], 0.5% NaCl). <br />  <br />                                                                      Antibodies <br /> Figure 1. Biosynthetic pathway sphingolipids S. cerevisiae.    Antisera Scs2, Ret1, Sec21 kindly provided Dr. Satoshi <br /> Precursors, products, proteins required individual    Kagiwada (Nara Women&#226;&#8364;&#8482;s University, Nara, Japan), Dr. Pierre Cosson (Basel <br /> zymatic steps shown. DHS, dihydrosphingosine; PHS, phyto-        Institute Immunology, Basel, Switzerland), Dr. Rainer Duden (Uni- <br /> <span id='am-130' about='obo:IMR_0100178' typeof='obo:IMR_0100022 owl:Thing obo:IMR_0000947 obo:IMR_0001359 obo:IMR_0000001 obo:IMR_0001362'><span id='am-131' property="rdfs:label" content="sph" datatype="xsd:string"></span><span id='am-132' property="oboInOwl:hasExactSynonym" content="Sphingenine" datatype="xsd:string"></span><span id='am-133' property="rdfs:label" content="sphingosine" datatype="xsd:string"></span><span id='am-134' property="oboInOwl:hasDbXref" content="KEGG:C00319" datatype="xsd:string"></span><span id='am-135' property="rdfs:label" content="Sphingenine" datatype="xsd:string"></span><span id='am-136' property="rdfs:label" content="sphingenine" datatype="xsd:string"></span><span id='am-137' property="oboInOwl:hasExactSynonym" content="sphingenine" datatype="xsd:string"></span><span id='am-138' property="rdfs:label" content="Sphingoid" datatype="xsd:string"></span><span id='am-139' property="oboInOwl:hasExactSynonym" content="sph" datatype="xsd:string"></span><span id='am-140' property="oboInOwl:id" content="IMR:0100178" datatype="xsd:string"></span><span id='am-141' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-142' property="oboInOwl:hasExactSynonym" content="Sphingoid" datatype="xsd:string"></span>sphingosine</span>; IPC, inositolphosphorylceramide.                        versity Cambridge, Cambridge, United Kingdom), respectively. Anti-3- <br />                                                                      phosphoglycerate kinase mouse (anti-PGK, 22C5; Invitrogen, Carlsbad, CA), <br />                                                                      anti-myc mouse (9E10; Berkeley Antibody, Richmond, CA), anti-hemaggluti- <br />                                                                      nin (HA) mouse (12CA5; Roche Diagnostics, Indianapolis, , anti- <br />                                                                      carboxypeptidase Y (CPY) rabbit (Rockland Immunochemicals, Gilbertsville, <br />    Sphingolipids attracted attention             PA) polyclonal antibody purchased. anti-green fluorescent protein <br /> searchers, striking advances field             (GFP), anti-Sed5, anti-Van1, anti-Kex2, anti-Gas1 antisera prepared past couple decades. Initially, genetic ap-           immunizing rabbits <span id='am-93' about='obo:IMR_0200318' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-94' property="oboInOwl:id" content="IMR:0200318" datatype="xsd:string"></span><span id='am-95' property="oboInOwl:hasDbXref" content="KEGG:C00051" datatype="xsd:string"></span><span id='am-96' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-97' property="rdfs:label" content="Glutathione" datatype="xsd:string"></span>glutathione</span> transferase (GST) fusion protein <br />                                                                      antigen. Western blotting, antisera diluted 1:1000. <br /> proaches isolating mutants, screening suppres- <br /> sors, searching homologues known genes related sphingolipids mainly contributed advances;           Construction Temperature-sensitive Mutant Allele recently, different approaches discovered novel            KEI1 <br /> proteins involved <span id='am-25' about='obo:IMR_0001359' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001362'><span id='am-26' property="oboInOwl:hasDbXref" content="CHEBI:26739" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="sphingolipid" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:id" content="IMR:0001359" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>sphingolipid</span> biosynthetic pathway.          DNA fragment containing KEI1 gene authentic <br />                                                                      promoter terminator amplified error-prone polymerase <br /> Riezman&#226;&#8364;&#8482;s group Lip1 purification           chain reaction (PCR) condition (Muhlrad et al., 1992). KSY66 transformed <br /> ceramide synthase complex (Vallee Riezman, 2005),            mixture amplified fragment SmaI-cleaved pKS26 Weissman&#226;&#8364;&#8482;s group uncovered previously unidentified                 integrate fragments plasmid gap repair.  transformants <br /> 3-hydroxyacyl-<span id='am-73' about='obo:IMR_0200354' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-74' property="oboInOwl:hasDbXref" content="KEGG:C00010" datatype="xsd:string"></span><span id='am-75' property="rdfs:label" content="CoA" datatype="xsd:string"></span><span id='am-76' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-77' property="oboInOwl:id" content="IMR:0200354" datatype="xsd:string"></span>CoA</span> dehydratase Phs1 large-scale             replicated 5-FOA plates remove pKS23 26.5&#194;&#176;C repli- <br />                                                                      cated phloxine B plates incubated 37&#194;&#176;C 4 &#226;&#8364;&#8220;12 h. Cells analysis essential genes products located        reduced viability unable protect entry dye. cells early secretory pathway (Denic Weissman, 2007).            formed pink colonies tested single colony formation 26.5 37&#194;&#176;C. <br /> findings indicate possibility essential genes           confirming temperature sensitivity plasmid, involved sphingolipid biosynthesis remain unidentified.           <span id='am-78' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-79' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-81' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-82' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-83' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-84' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-85' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span>nucleotide</span> sequences mutant kei1 determined. allele kei1-1 <br />                                                                      integrated chromosome KSY66 &#226;&#338;&#172;kei1::kanMX4 region probably difficult conventional ap-            recombination kei1-1::LEU2 fragment double crossing proaches.                                                            surrounding homologous sequences. Leu&#226;&#171;&#185; cells streaked    S. cerevisiae genome, &#226;&#172;&#381;200 genes encode membrane           5-FOA plate remove pKS23, grown cells tested genotype, proteins essential cell viability. spite enormous          correct strain stocked KSY271. <br /> efforts genome-wide analyses, essential mem- <br /> brane proteins remain uncharacterized. tried              Subcellular Fractionation <br /> assign functions essential proteins inte-           Cells converted spheroplasts burst B88 (20 mM HEPES, pH 6.8, <br />                                                                      150 mM potassium acetate, 5 mM magnesium acetate, 200 mM sorbitol) <br /> grated membranes strategy using tempera-              containing protease inhibitors (1 &#226;&#65533;&#174;g/ml chymostatin, aprotinin, leu- <br /> ture-sensitive mutants. <span id='am-30' about='oboInOwl:date' typeof='owl:Thing'>date</span>, reported char-          peptin, pepstatin  antipain, 1 mM phenylmethylsulfonyl fluoride). <br /> acterization previously uncharacterized endoplasmic           Unbroken cells removed centrifugation 1000 &#226;&#171;&#187; g 5 min. reticulum (ER) proteins Pga1 Keg1 (Nakamata et al.,              differential fractionation, cleared lysate sequentially centrifuged                                                                      generate 10,000 &#226;&#171;&#187; g &#226;&#171;&#187; 10-min pellet (P10), 100,000 &#226;&#171;&#187; g &#226;&#171;&#187; 60-min pellet (P100), <br /> 2007; Sato et al., 2007). YDR367w uncharacter-        100,000 &#226;&#171;&#187; g &#226;&#171;&#187; 60-min supernatant (S100). fraction adjusted ized essential gene, encoding 221-amino acid polypeptide           original volume lysate, applied predicted transmembrane domains.                   SDS-polyacrylamide gel electrophoresis (PAGE) Western blotting. <br />  <br />  <br /> Vol. 20, October 15, 2009                                                                                                                      4445 <br />  K. Sato et al. <br />  <br />  <br />  <br /> Table 1. Strains used study <br />  <br /> Strain                                                            Description                                                                Source <br />  <br /> KA31a                      MATa, &#226;&#338;&#172;his3&#226;&#338;&#172; leu2&#226;&#338;&#172; trp1&#226;&#338;&#172; ura3                                                                                    EUROSCARFa <br /> BY4741                     MATa, his3&#226;&#338;&#172;1 leu2&#226;&#338;&#172;0 met15&#226;&#338;&#172;0 ura3&#226;&#338;&#172;0                                                                               EUROSCARF <br /> BY4742                     MATa, his3&#226;&#338;&#172;1 leu2&#226;&#338;&#172;0 met15&#226;&#338;&#172;0 ura3&#226;&#338;&#172;0                                                                               EUROSCARF <br /> BY4743                     MATa/MAT&#226;&#65533;&#163;, his3&#226;&#338;&#172;1/his3&#226;&#338;&#172;1 leu2&#226;&#338;&#172;0/leu2&#226;&#338;&#172;0 met15&#226;&#338;&#172;0/MET15 LYS2/lys2&#226;&#338;&#172;0 ura3&#226;&#338;&#172;0/ura3&#226;&#338;&#172;0                                   EUROSCARF <br /> KSY66                      BY4741, &#226;&#338;&#172;kei1::kanMX4, pKS23 (CEN, URA3 KEI1)                                                                 study <br /> KSY271                     BY4741, &#226;&#338;&#172;kei1::kei1-1 LEU2                                                                                    study <br /> KSY431                     BY4741, &#226;&#338;&#172;kei1::kanMX4, pKS243 (CEN, HIS3 KEI1-GFP)                                                            study <br /> KSY506                     BY4743, &#226;&#338;&#172;kei1::kanMX4/KEI1                                                                                    study <br /> KSY507                     BY4741, &#226;&#338;&#172;kei1::kanMX4, pKS301 (CEN, HIS3 KEI1&#226;&#171;&#186;intron-GFP)                                                     study <br /> KSY512                     BY4741, &#226;&#338;&#172;aur1::AUR1-GFP HIS3                                                                                  study <br /> KSY513                     KSY271, &#226;&#338;&#172;aur1::AUR1-GFP HIS3                                                                                  study <br /> KSY525                     BY4741, &#226;&#338;&#172;aur1::AUR1&#226;&#8364;&#8220;3HA HIS3                                                                                  study <br /> KSY527                     BY4741, &#226;&#338;&#172;kei1::KEI1-GFP URA3                                                                                  study <br /> KSY530                     KSY271, &#226;&#338;&#172;aur1::AUR1&#226;&#8364;&#8220;3HA HIS3                                                                                  study <br /> KSY531                     BY4741, &#226;&#338;&#172;aur1::AUR1&#226;&#8364;&#8220;3HA HIS3, &#226;&#338;&#172;kei1::KEI1-GFP URA3                                                            study <br /> KSY548                     BY4741, &#226;&#338;&#172;kex2::kanMX4                                                                                         EUROSCARF <br /> KSY552                     KSY271, &#226;&#338;&#172;ubc7::kanMX4                                                                                         study <br /> KSY553                     KSY271, &#226;&#338;&#172;ubc7::kanMX4                                                                                         study <br /> KSY554                     KSY271, &#226;&#338;&#172;doa10::kanMX4                                                                                        study <br /> KSY559                     KSY271, &#226;&#338;&#172;hrd1::kanMX4                                                                                         study <br /> KSY560                     KSY271, &#226;&#338;&#172;hrd1::kanMX4                                                                                         study <br /> KSY561                     KSY271, &#226;&#338;&#172;doa10::kanMX4                                                                                        study <br /> KSY562                     KSY271, &#226;&#338;&#172;ubx2::kanMX4                                                                                         study <br /> KSY563                     KSY271, &#226;&#338;&#172;ubx2::kanMX4                                                                                         study <br /> KSY571                     KSY512, &#226;&#338;&#172;pep4::LEU2                                                                                           study <br /> KSY572                     KSY513, &#226;&#338;&#172;pep4::LEU2                                                                                           study <br /> KSY607                     BY4741, pKS342 (CEN, URA3 kei1K141S-GFP)                                                                      study <br /> KSY609                     BY4741, pKS344 (CEN, URA3 kei1R135S-GFP)                                                                      study <br /> KSY611                     BY4741, pKS346 (CEN, URA3 kei1K131S-GFP)                                                                      study <br /> KSY614                     KSY548, pKS342 (CEN, URA3 kei1K141S-GFP)                                                                      study <br /> KSY616                     KSY548, pKS344 (CEN, URA3 kei1R135S-GFP)                                                                      study <br /> KSY618                     KSY548, pKS346 (CEN, URA3 kei1K131S-GFP)                                                                      study <br /> KSY625                     BY4741, pKS353 (CEN, URA3 KEI1-GFP)                                                                           study <br /> KSY627                     KSY548, pKS353 (CEN, URA3 KEI1-GFP)                                                                           study <br /> KSY686                     BY4741, &#226;&#338;&#172;kei1::kanMX4, ura3-52:: KEI1-GFP, URA3                                                               study <br /> KSY692                     BY4741, &#226;&#338;&#172;kei1::kanMX4, ura3-52:: kei1-1-GFP, URA3                                                             study <br /> KSY694                     BY4741, &#226;&#338;&#172;kei1::kanMX4, ura3-52:: kei1&#226;&#338;&#172;C-GFP, URA3                                                             study <br /> KSY696                     BY4741, &#226;&#338;&#172;kei1::kanMX4, ura3-52:: KEI1-GFP, URA3                                                               study <br /> KSY698                     BY4741, &#226;&#338;&#172;kei1::kanMX4, ura3-52:: kei1F103I-GFP, URA3                                                          study <br /> KSY714                     KSY527, &#226;&#338;&#172;kre2::KRE2&#226;&#8364;&#8220;3HA LEU2                                                                                  study <br /> KSY721                     KSY525, ura3-52::GFP-KEI1, URA3                                                                               study <br /> KSY723                     BY4741, ura3-52::GFP-KEI1, URA3                                                                               study <br /> KSY725                     KSY723, &#226;&#338;&#172;kre2::KRE2&#226;&#8364;&#8220;3HA LEU2                                                                                  study <br /> KSY728                     KSY692, &#226;&#338;&#172;pep4::LEU2                                                                                           study <br /> KSY730                     KSY694, &#226;&#338;&#172;pep4::LEU2                                                                                           study <br /> KSY732                     KSY696, &#226;&#338;&#172;pep4::LEU2                                                                                           study <br /> KSY753                     BY4741, &#226;&#338;&#172;kei1::kanMX4, ura3-52:: GFP-kei1F103I, URA3                                                          study <br /> KSY765                     KSY723, &#226;&#338;&#172;pep4::LEU2                                                                                           study <br /> KSY767                     KSY753, &#226;&#338;&#172;pep4::LEU2                                                                                           study <br /> KSY771                     BY4741, &#226;&#338;&#172;kei1::kanMX4, pKS380 (CEN, LEU2 KEI1-GFP), &#226;&#338;&#172;aur1::AUR1-3HA HIS3                                      study <br /> KSY773                     BY4741, &#226;&#338;&#172;kei1::kanMX4, pKS381 (CEN, LEU2 kei1F103I-GFP), &#226;&#338;&#172;aur1::AUR1-3HA HIS3                                 study <br /> KSY775                     BY4741, &#226;&#338;&#172;kei1::kanMX4, pKS382 (CEN, LEU2 kei1&#226;&#338;&#172;C-GFP), &#226;&#338;&#172;aur1::AUR1-3HA HIS3                                    study <br /> KSY780                     KSY698, &#226;&#338;&#172;pep4::LEU2                                                                                           study <br /> KSY784                     KSY271, &#226;&#338;&#172;kre2::KRE2-3HA HIS3                                                                                  study <br /> KSY790                     BY4741, &#226;&#338;&#172;kre2::KRE2-3HA HIS3                                                                                  study <br /> KSY792                     KSY696, &#226;&#338;&#172;aur1::AUR1-3HA HIS3                                                                                  study <br /> KSY794                     KSY698, &#226;&#338;&#172;aur1::AUR1-3HA HIS3                                                                                  study <br /> KSY799                     BY4741, &#226;&#338;&#172;kei1, ura3-52:: GFP-kei1F103I, URA3                                                                  study <br /> KSY801                     KSY753, &#226;&#338;&#172;aur1::AUR1-3HA HIS3                                                                                  study <br /> KSY805                     BY4741, &#226;&#338;&#172;kei1::kei1 F103I LEU2, &#226;&#338;&#172;aur1::AUR1-3HA HIS3                                                          study <br /> THY4-2                     KA31a, &#226;&#338;&#172;kre2::KRE2-3HA LEU2                                                                                   study <br /> YNY309                     sec12-4                                                                                                          Randy Schekman <br /> YNY401                     &#226;&#338;&#178;&#226;&#338;&#169;31&#226;&#65533;&#163;, &#226;&#338;&#172;emp24                                                                                                 study     EUROpean Saccharomyces Cerevisiae ARchive Functional Analysis, Frankfurt, Germany. <br />  <br />  <br />   Fractionations using 22&#226;&#8364;&#8220; 60% sucrose density gradient centrifugation      al., 1999). brief, spheroplasts lysed 1 ml ice-cold B88 containing <br /> performed basically described previously (Becherer et al., 1996; Conchon et   protease inhibitors incubation 30 min 4&#194;&#176;C sequential 20 strokes <br />  <br />  <br /> 4446                                                                                                                         Molecular Biology Cell <br />                                                                                                                       Novel Subunit Yeast IPC Synthase <br />  <br />  <br />  <br /> Table 2. Plasmids used study <br />  <br /> Plasmid                                                          Description                                                               Source <br />  <br /> pKS23                                               CEN-URA3-KEI1, promoter                                                        study <br /> pKS26                                               Gap-repair KEI1, CEN, HIS3                                                     study <br /> pKS181                                              kei1-1 integration (LEU2)                                                          study <br /> pKS243                                              CEN-HIS3-KEI1-GFP, promoter                                                    study <br /> pKS262                                              2&#226;&#65533;&#174;URA3-AUR1, promoter                                                          study <br /> pKS290                                              AUR1-GFP integration (HIS3)                                                        study <br /> pKS293                                              AUR1-3HA integration (HIS3)                                                        study <br /> pKS301                                              CEN, HIS3 KEI1&#226;&#171;&#186;intron-GFP, promoter                                            study <br /> pKS307                                              KEI1-GFP integration (URA3)                                                        study <br /> pKS342                                              CEN, URA3 kei1K141S-GFP, promoter                                              study <br /> pKS344                                              CEN, URA3 kei1R135S-GFP, promoter                                              study <br /> pKS346                                              CEN, URA3 kei1K131S-GFP, promoter                                              study <br /> pKS349                                              KEX2 disruption (LEU2)                                                             study <br /> pKS353                                              CEN, URA3 KEI1-GFP, promoter                                                   study <br /> pKS360                                              PEP4 disruption (LEU2)                                                             study <br /> pKS361                                              URA3-kei1-1-GFP                                                                    study <br /> pKS362                                              URA3-kei1&#226;&#338;&#172;C-GFP                                                                    study <br /> pKS363                                              URA3-KEI1-GFP                                                                      study <br /> pKS364                                              URA3-kei1F103I-GFP                                                                 study <br /> pKS378                                              URA3-GFP-KEI1, YPT1 promoter                                                       study <br /> pKS380                                              CEN-LEU2-KEI1, promoter                                                        study <br /> pKS381                                              CEN-LEU2-kei1F103I, promoter                                                   study <br /> pKS382                                              CEN-LEU2-kei1&#226;&#338;&#172;C, promoter                                                      study <br /> pKS384                                              URA3-GFP-KEI1F103I, YPT1 promoter                                                  study <br /> pKS393                                              KRE2&#226;&#8364;&#8220;3HAs integration (HIS3)                                                       study <br /> pKS394                                              kei1F103I integration (LEU2)                                                       study <br /> pHI63                                               KEX2 disruption (URA3)                                                             Tomishige et al. (2003) <br /> pTH6-3                                              KRE2-3HA integration                                                               study <br />  <br />  <br />  Dounce homogenizer. lysate centrifuged 1000 &#226;&#171;&#187; g 5 min           SDS-PAGE. Indicated proteins detected Western blot- remove unlysed cells.  0.65 ml supernatant recovered,        ting. pellet extracted 0.45 ml ice-cold B88 containing protease <br /> inhibitors centrifuged 1000 &#226;&#171;&#187; g 5 min. combined supernatant          Vitro Assay IPC Synthesis centrifuged 10,000 &#226;&#171;&#187; g 10 min, 1 ml resultant supernatant <br />                                                                                     membrane fractions, cells grown 26.5&#194;&#176;C OD600 nm &#226;&#171;&#189; 1.0. Half loaded sucrose step gradient, generated using                                                                                     cells grown 26.5&#194;&#176;C, half grown 37&#194;&#176;C following steps  sucrose solutions [wt/wt, %], 10 mM <br />                                                                                     2 h. Cells collected, washed water B88, suspended HEPES-KOH, pH 7.6, 1 mM MgCl2): 1 ml 60%, 1 ml 40%, 1.2 ml 37%, 1.8 ml <br /> 34%, 2 ml 32%, 1.8 ml 29%, 1.2 ml 27%, 1 ml 22%. 16-h centrifuga-         ice-cold B88 containing protease inhibitors. mixture added 1 g <br /> tion SW40Ti rotor (Beckman Coulter, Fullerton, CA) 170,000 &#226;&#171;&#187; g, 12         glass beads broken Multi-Beads Shocker (Yasui Kikai, Osaka, <br /> fractions 1 ml sequentially collected gradient.         Japan). Unbroken cells removed centrifugation 1000 &#226;&#171;&#187; g 5 min <br /> Aliquots fraction mixed SDS sample buffer, pro-           4&#194;&#176;C, supernatant centrifuged 60% sucrose cushion teins resolved SDS-PAGE detected immunoblotting using                100,000 &#226;&#171;&#187; g 30 min (TLS-55 rotor; Beckman Coulter). membrane <br /> anti-Kex2, anti-Sed5, anti-GFP, anti-HA antisera. Enhanced chemilumi-           fraction suspended ice-cold B88 containing protease inhibitors, dis- <br /> nescence signals captured image analyzer equipped cooled          pensed 60 &#226;&#65533;&#174;l  frozen liquid N2, preserved &#226;&#171;&#186;80&#194;&#176;C                                                                                     used. membrane fraction mixed 60 &#226;&#65533;&#174;l reaction mix <br /> charge-coupled-device camera (LAS-1000plus; Fuji Film, Tokyo, Japan),                                                                                     (10 mM HEPES-KOH, pH 7.2, 1 mM EDTA, 250 mM sucrose, 10 mg/ml <br /> digital images quantified using ImageJ software (National Institutes                                                                                     bovine serum albumin BSA [fatty acid-free; Sigma-Aldrich], 2 mM 3-[(3- <br /> Health, Bethesda, MD) graphed Excel (Microsoft, Redmond, WA). <br />                                                                                     cholamidopropyl)dimethylammonio]propanesulfonate [CHAPS, Dojindo, <br />    fractionation using 18 &#226;&#8364;&#8220; 60% sucrose density gradient centrifugation, <br />                                                                                     Kumamoto, Japan], 2 mM MnCl2, 2 mM MgCl2) 10 <br /> spheroplasts lysed described  1 ml supernatant 1000 &#226;&#171;&#187; g loaded sucrose step gradient described <br />                                                                                     &#226;&#65533;&#174;g/ml aureobasidin (Takara Bio), incubated indicated temper- <br />                                                                                     ature 30 min (preincubation).  0.6 &#226;&#65533;&#174;l 1 M 6-((N-(7-nitrobenz-2- <br /> previously (Inadome et al., 2005). quantification digital images                                                                                     oxa-1,3-diazol-4-yl)amino)hexanoyl)sphingosine (C6-NBD-ceramide; Invitro- <br /> creation graph carried described  <br />                                                                                     gen) dissolved dimethyl sulfoxide added mixture incubated <br />                                                                                     indicated temperature 1 h. reaction stopped adding 400 <br />                                                                                     &#226;&#65533;&#174;l 4:10:1 mixture chloroform:methanol:1 M HCl. Lipids extracted <br /> Immunoprecipitation                                                                 sequential additions 50 &#226;&#65533;&#174;l 1 M HCl 100 &#226;&#65533;&#174;l chloroform Cells grown 30&#194;&#176;C YPD medium OD600 nm &#226;&#171;&#189; 1.0, 50             vigorously vortexing, phase separation achieved centrif- <br /> OD units cells converted spheroplasts suspended 1 ml B88       ugation 5 min 16,100 &#226;&#171;&#187; g. chloroform layer collected dried <br /> containing 1% Triton X-100 protease inhibitors. rotating mixture      evaporation Speed-Vac, resulting pellet resuspended 30 min 4&#194;&#176;C, unbroken cells removed centrifugation 1000 &#226;&#171;&#187;          15 &#226;&#65533;&#174;l chloroform. Recovered lipids separated layer chro- <br /> g 5 min 4&#194;&#176;C centrifuged 16,100 &#226;&#171;&#187; g 10 min.               matography (TLC) plate (Silica gel 60; Merck, White Station, NJ) 11:9:2 <br /> supernatant centrifuged 100,000 &#226;&#171;&#187; g 60 min. super-         mixture chloroform:methanol:30 mM KCl. Fluorescent bands TLC <br /> natant recovered fraction &#226;&#8364;&#339;supernatant.&#226;&#8364;&#65533; rest superna-        detected using LAS-1000plus. <br /> tant mixed anti-HA antibody kept gently rotating 4&#194;&#176;C 1 h.          assay immunologically purified IPC synthase, cells grown <br /> Protein Sepharose beads (Amersham Biosciences, Uppsala, Sweden)                   26.5&#194;&#176;C OD600 nm &#226;&#171;&#189; 1.0, 50 OD units cells converted washed B88 containing 1% Triton X-100 added, incubation           spheroplasts suspended 1 ml B88 containing 1% Triton X-100 continued 4&#194;&#176;C overnight. mixture centrifuged                          protease inhibitors. rotating mixture 30 min 4&#194;&#176;C, unbroken <br /> 500 &#226;&#171;&#187; g 1 min, supernatant recovered fraction             cells removed centrifugation 1000 &#226;&#171;&#187; g 5 min 4&#194;&#176;C bound.&#226;&#8364;&#65533; beads washed times 500 &#226;&#65533;&#174;l B88 containing 1%           centrifuged 16,100 &#226;&#171;&#187; g 10 min 4&#194;&#176;C. supernatant centrifuged <br /> Triton X-100. bound proteins eluted twice incubating 4&#194;&#176;C         100,000 &#226;&#171;&#187; g 60 min 4&#194;&#176;C. supernatant mixed washed <br /> 10 min 50 &#226;&#65533;&#174;l SDS sample buffer recovered fraction &#226;&#8364;&#339;bound.&#226;&#8364;&#65533;         protein Sepharose beads 30 min 4&#194;&#176;C, centrifuged 500 &#226;&#171;&#187; <br /> Material derived 10-fold cells loaded sample bound           g 1 min 4&#194;&#176;C. supernatant mixed anti-HA antibody  <br />  <br /> Vol. 20, October 15, 2009                                                                                                                                  4447 <br />  K. Sato et al. <br />  <br /> kept gently rotating 4&#194;&#176;C 1 h. Washed protein Sepharose beads       shown). Interestingly, Kei1-GFP yielded major bands <br /> added, incubation continued 4&#194;&#176;C overnight. mixture            resolved detected SDS-PAGE Western <br /> centrifuged 500 &#226;&#171;&#187; g 1 min, beads washed twice 1 ml B88 containing 1% Triton X-100. beads washed           blotting estimated molecular masses 36.5 27 <br /> times 1 ml B88 containing 1 mM CHAPS. supernatant                kDa (Figure 3A). fractionated differential cen- <br /> removed resuspended 1 ml B88 containing 1 mM CHAPS                 trifugation, 36.5-kDa polypeptide mainly recovered <br /> dispensed tubes (500, 250, 2 &#226;&#171;&#187; 125 &#226;&#65533;&#174;l). tube centrifuged   P10 fraction, 27-kDa evenly 500 &#226;&#171;&#187; g 1 min, supernatant completely removed. Bound <br /> proteins beads 125-&#226;&#65533;&#174;l dispensed tube eluted 1&#226;&#171;&#187; SDS-          P10 P100 fractions (Figure 3A). result, PAGE sample buffer monitor bound proteins. Beads       likely 36.5-kDa polypeptide localized ER tubes resuspended 120 &#226;&#65533;&#174;l reaction mix (10 mM HEPES-KOH,           27-kDa polypeptide localized Golgi.  pH 7.2, 1 mM EDTA, 250 mM sucrose, 5 mg/ml fatty acid-free BSA, 1 mM             types Kei1 polypeptides, CHAPS, 2 mM MnCl2, 2 mM MgCl2, 0.15 mg/ml l-&#226;&#65533;&#163;-phosphatidylinositol <br /> ammonium salt bovine liver [Sigma-Aldrich], 0.05% Triton X-100).        different molecular mass subcellu- preincubation 26.5&#194;&#176;C 30 min, reaction started adding     lar localization. <br /> 0.6 &#226;&#65533;&#174;l 1 M C6-NBD-ceramide. incubation 26.5&#194;&#176;C 1 h, lipids       KEI1 contains intron 31 nucleotides predicted extracted analyzed explained                                   start site translation. tested intron                                                                                  result types Kei1 polypeptides, deletion GST Pull Assay                                                              intron did affect pattern Kei1-GFP SDS-PAGE <br /> E. coli BL21 (DE3) cells transformed plasmid pKSEC7 (GST-Kei1CT)        (Figure 3B). result consistent analyses pGEX4T-3 (GST) grown 37&#194;&#176;C LB medium containing ampi- <br /> cillin (100 &#226;&#65533;&#174;g/ml), protein production induced addition        transcripts (Miura et al., 2006) transcription start sites <br /> isopropyl &#226;&#65533;&#164;-d-thiogalactoside (final concentration, 0.5 mM) OD600 nm        (Zhang Dietrich, 2005) S. cerevisiae, indicate <br /> reached 0.5. cultures grown 37&#194;&#176;C additional 2 h. cells    transcript KEI1.  suspected collected centrifugation, resuspended STE buffer (10 mM      Kei1 undergoes processing transported Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA) containing 100 &#226;&#65533;&#174;g/ml <br /> lysozyme, kept ice 20 min. Protease inhibitors dithiothreitol     Golgi. Kex2 major protease Golgi <br /> (final concentration, 1 mM) added mixture,            (Fuller et al., 1989; Redding et al., 1991), tested sonicated 1 min ice bath UD-201 Ultrasonic Disruptor (Tomy,     Kex2 process Kei1. Kei1-GFP expressed wild- <br /> Tokyo, Japan) appropriate setting (output, 4; duty cycle, 40%).     type &#226;&#338;&#172;kex2 cells, molecular mass Kei1-GFP cell homogenate centrifuged, supernatant mixed  <br /> ninth volume 10% Triton X-100. Glutathione-Sepharose 4B beads (GE             analyzed SDS-PAGE. result, 27-kDa band Healthcare, Little Chalfont, Buckinghamshire, United Kingdom) added         diminished KEI1-GFP expressed &#226;&#338;&#172;kex2 cells mixture rotated gently 2 h 4&#194;&#176;C. Protein-bound beads       (Figure 3C). Kex2 prefers basic residues, especially dibasic <br /> washed times ice-cold phosphate-buffered saline. yeast cytosol      sequences, cleavage site (Rockwell Fuller, 1998). <br /> prepared BY4741 mixed Triton X-100 (final concentration, 1%), <br /> added beads containing purified GST-Kei1CT, gently rotated        predicted apparent molecular masses 2 h 4&#194;&#176;C. extensive washing, bound proteins eluted boiling   species Kei1-GFP cleavage occurs beads SDS sample buffer subjected SDS-PAGE. released           fourth predicted transmembrane segments, proteins detected Western blotting.                                      replaced basic residues region <br />                                                                                  (131Lys, 135Arg, 141Lys) Ser. modified Kei1-GFP <br /> Indirect Immunofluorescence <br />                                                                                  constructs produced wild-type &#226;&#338;&#172;kex2 cells. localization Aur1-3HA Kre2-3HA observed indirect <br /> immunofluorescence described previously (Sato et al., 2007)                                                                                  shown Figure 3C, R135S substitution resulted anti-HA antibody Alexa 568-conjugated goat antibody mouse immu-           disappearance 27-kDa Kei1-GFP band wild- <br /> noglobulin G used primary antibody secondary antibody,       type cells, indicating Kex2 recognizes 135Arg resi- <br /> respectively.                                                                    cleave Kei1. results, propose                                                                                  Kei1 transported late Golgi subsequently <br /> Invertase Detection                                                              processed Kex2. length Kei1 Secretory invertase recovered analyzed described previously (Sato     Kei1F, N- C-terminal fragments Kei1N et al., 2007). <br />                                                                                  Kei1C, respectively. <br />                                                                                      carried solubility test Kei1-GFP RESULTS                                                                          Kei1F-GFP Kei1C-GFP                                                                                  precipitate 100,000 &#226;&#171;&#187; g centrifugation Kei1/Ydr367w Conserved Fungi                                            cell lysate treated 1 M sodium chloride, 0.1 M <br /> According Saccharomyces Genome Database, KEI1/                                sodium carbonate, pH 11.0, 2 M <span id='am-143' about='obo:IMR_0200111' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-144' property="rdfs:label" content="Urea" datatype="xsd:string"></span><span id='am-145' property="oboInOwl:id" content="IMR:0200111" datatype="xsd:string"></span><span id='am-146' property="oboInOwl:hasDbXref" content="KEGG:C00086" datatype="xsd:string"></span><span id='am-147' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>urea</span>.  YDR367w encodes 221-amino acid polypeptide molec-                           treatment 1% Triton X-100, proteins ular weight 25,484 pI 8.06, biochemical function                      supernatant (Supplemental Figure S1A). addition, remains unknown. Homologous sequences                                 GFP-Kei1F GFP-Kei1N superna- fungal genome databases FASTAP                               tant treated 1% Triton X-100 (Supplemental <br /> search (Figure 2A), homologues data-                        Figure S1B).  Kex2 cleavage, fragments <br /> bases higher eukaryotes. hydropathy plot indicated                        Kei1 remain integrated membrane, predicted hydrophobic segments, pre-                         hydropathy profile. <br /> dicted transmembrane helices TMHMM program <br /> (http://www.cbs.dtu.dk/services/TMHMM/) (Figure 2B).                             Kei1 Localizes Medial-Golgi Kex2 Cleavage <br />                                                                                  determine localization Kei1 precisely, Kei1 Integral Membrane Protein Undergoes                               constructed strain express KEI1-GFP KRE2-3HA <br /> Cleavage Kex2                                                                 loci chromosome pro- constructed plasmid produces Kei1 C-                          moters, investigated Kei1 localizes cell <br /> terminally fused green fluorescent protein (Kei1-GFP)                       ways. introduced diploid strain KEI1                       compared localization Kei1C-GFP alleles disrupted kanMX4. tetrad analysis, hap-                      early Golgi-marker Van1, medial-Golgi-marker Kre2- <br /> loid disruptant strain producing fusion protein ob-                      3HA late Golgi-marker Kex2 subcellular fraction- <br /> tained. Kei1-GFP fully rescued &#226;&#338;&#172;kei1 disruption                      ation. cell lysate centrifuged 10,000 &#226;&#171;&#187; g 10 <br /> KEI1-GFP cells showed apparent growth defects (data                       min remove ER fraction, resulting supernatant <br />  <br /> 4448                                                                                                                Molecular Biology Cell <br />                                                                                            Novel Subunit Yeast IPC Synthase <br />  <br />  <br />  <br />  <br /> Figure 2. Sequence alignment Kei1 pro- <br /> tein homologues hydropathy <br /> profile Kei1 protein.   Amino acid se- <br /> quence alignment Kei1 homologues. <br /> Transmembrane domains predicted TMHMM program indicated bars sequences. C-terminal <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>peptide</span> fused GST Figure 9 (Kei1CT) indicated dotted line. sequence alterations kei1-1 (F103I &#226;&#338;&#172;C) indicated arrows. Kex2 recognition residue (135R) indi- <br /> cated arrowhead. identical amino <br /> acids highlighted reverse letters. <br /> S.c., S. cerevisiae; C.g., Candida glabrata; V.p., <br /> Vanderwaltozyma polyspora; g., Ashbya gossy- <br /> pii; K.l., Kluyveromyces lactis. (B) hy- <br /> drophobicity index calculated according Kyte Doolittle (1982) window <br /> size 19 amino acids. Bold lines indicate hydrophobic domains. <br />  <br />  <br />  loaded 22&#226;&#8364;&#8220; 60% sucrose density gradient,        Kei1 localizes medial-Golgi compartment proteins fractionated ultracentrifugation. Dis-   Kex2 cleavage. <br /> tribution indicated proteins analyzed SDS- <br /> PAGE Western blotting. shown Figure 4A,          Isolation kei1-1, Temperature-sensitive Allele KEI1 <br /> peak Kei1C-GFP peaks Sed5          investigate function Kei1 exerts medial-Golgi, Kex2 exhibited similar distribution Kre2-    sought temperature-sensitive (ts) alleles KEI1 error- <br /> 3HA, indicating Kei1C-GFP localizes medial-        prone PCR mutagenesis. obtained ts allele kei1-1, Golgi.  examined localization Kei1-GFP,         base substitution caused replacement 103Phe GFP-Kei1, Kre2-3HA confocal laser microscopy            Ile (F103I) nucleotide deletion caused truncation (Figure 4B). Kei1-GFP GFP-Kei1 signals showed              C-terminal region 193Gln- . . . -221Glu-COOH 193Lys- <br />                                                                194 <br /> punctate patterns cytoplasm,                Thr-COOH (&#226;&#338;&#172;C). mutations required overlapped Kre2-3HA signals. Kei1-GFP           temperature sensitivity, cells carrying dots apparently coincident Kre2-3HA dots,        F103I &#226;&#338;&#172;C mutation form colonies similar extent GFP-Kei1 signals did coincide Kre2-3HA.          wild-type cells 37&#194;&#176;C (Supplemental Figure S2A). chro- probably correspond GFP-Kei1F ER,            mosomal KEI1 allele replaced mutant kei1-1 cause considerable uncleaved GFP-Kei1F         homologous recombination analysis. cofractionated ER-marker Scs2 su- <br /> crose density gradient centrifugation experiments (Sup-        Kei1 Genetically Physically Interacts Aur1 <br /> plemental Figure S1C). GFP-Kei1F abundant         test Kei1 involved protein transport Kei1F-GFP KRE2-3HA strains  Figure 6),       modification, processing carboxypeptidase Y, glyco- <br /> supports possibility. results, conclude     sylphosphatidylinositol (GPI)-anchored protein Gas1,  <br /> Vol. 20, October 15, 2009                                                                                               4449 <br />  K. Sato et al. <br />  <br />  <br />  <br />  <br /> Figure 3. Kei1 novel substrate late Golgi endoprotease <br /> Kex2.   KEI1-GFP expressed CEN plasmid. total cell <br /> lysate subjected differential centrifugation obtain indicated <br /> fractions. Proteins resolved detected SDS-PAGE Western blotting. bands molecular mass 36.5 kDa 27 kDa detected anti-GFP antibody. 36.5-kDa band mainly recovered P10 fraction, 27-kDa band recovered evenly P10 P100 fractions. early Golgi mem- <br /> brane protein Van1 detected anti-Van1 antibody. (B) Effect intron Kei1 protein size. KEI1 intron sequence expressed CEN plasmid proteins detected          Figure 4. Kex2-cleaved Kei1 localized medial-Golgi.   C-terminal GFP tag. (C) Kei1 protein derivatives      lysate cells expressing KEI1-GFP KRE2-3HA (KSY714) <br /> possible Kex2 cleavage sites. KEI1-GFP, KEIK131S-GFP, KEI1R135S-          centrifuged 10,000 &#226;&#171;&#187; g 10 min, supernatant <br /> GFP, KEI1K141S-GFP expressed CEN plasmid wild-             subjected 22&#226;&#8364;&#8220; 60% sucrose density gradient fractionation  type (&#226;&#171;&#185;) &#226;&#338;&#172;kex2 (&#226;&#171;&#186;) cells.                                             Materials Methods details). fraction subjected                                                                           SDS-PAGE, proteins detected Western blotting.                                                                           signal intensity indicated proteins quantified ImageJ <br />                                                                           software graphed Excel. (B) Localization Kei1 secretory invertase analyzed, apparent defects                C-terminal GFP tag (Kei1-GFP,  KSY714) Kei1 N-termi- observed analyses (Supplemental Figure                 nal GFP tag (GFP-Kei1,  KSY725) shown indirect <br /> S2, B&#226;&#8364;&#8220;D).                                                                 immunofluorescence medial-Golgi protein Kre2-3HA (Al- <br />     screened multicopy suppressor genes                exa568 anti-mouse). Bar, 5 &#226;&#65533;&#174;m. <br /> temperature sensitivity kei1-1 mutant, effective clue elucidate functional role uncharacterized gene products. constructed 2-&#226;&#65533;&#174;m                      Aur1-3HA identical (Supplemental Figure <br /> genomic library kei1-1 chromosome introduced                S1C).  investigated physical interaction kei1-1 cells screened colonies viability              Kei1 Aur1 vivo. lysate KEI1-GFP AUR1-3HA <br /> 37&#194;&#176;C depended introduced plasmids. Consequently,                   GFP-KEI1 AUR1-3HA cells treated 1% Triton identified AUR1, PSD1, GDA1, SFH1 (YKL091c)                     X-100 solubilize membrane. Aur1-3HA immuno- <br /> multicopy suppressors temperature sensitivity                   precipitated anti-HA antibody, GFP signal kei1-1 (Figure 5A Supplemental Figure S3). Importantly,               analyzed. Cells expressing KRE2-3HA instead AUR1-3HA <br /> AUR1 significantly recover growth defect                 used negative controls. shown Figure 6, kei1-1 mutant 37&#194;&#176;C (Figure 5A). AUR1 thought                 B, Kei1C-GFP GFP-Kei1N coprecipitated <br /> encode IPC synthase (Funato et al., 2002; Cowart Obeid,               Aur1-3HA, indicating Kei1 Aur1 form com- <br /> 2007). High copy introduction AUR1 gene sup-                 plex vivo. Coprecipitation Kei1F-GFP GFP-Kei1F <br /> press lethality &#226;&#338;&#172;kei1 null mutant (Figure 5B),                 Aur1-3HA efficient, reproducibly <br /> indicating Kei1 indispensable role related                 observed coprecipitated band. indicate Aur1.                                                                     Aur1 interacts Kei1F arrived late <br />    strong suppressor activity AUR1 suggests               Golgi compartment Kex2 cleaves Kei1. <br /> kei1-1 mutant defects IPC synthesis. tested kei1-1 mutant altered sensitivity               Activity IPC Synthase Significantly Decreases <br /> aureobasidin  specific inhibitor IPC synthase (Nagiec              kei1-1 Mutant <br /> et al., 1997). kei1-1 mutant showed strong hypersensi-              vivo interaction Kei1 Aur1, addition tivity inhibitor (Figure 5C), supports              hypersensitivity aureobacidin kei1-1 cells, led direct involvement Kei1 IPC synthesis.                          suppose Kei1 essential IPC synthase activity. <br />    total cell lysate subjected sucrose density             tested membrane preparation <br /> gradient centrifugation, distribution Kei1C-GFP                kei1-1 mutant difference activity  <br /> 4450                                                                                                           Molecular Biology Cell <br />                                                                                                       Novel Subunit Yeast IPC Synthase <br />  <br />  <br />  <br />  <br />                                                                         Figure 6. Kei1 subunit IPC synthase complex.                                                                           lysate KRE2-3HA KEI1-GFP (KSY714) AUR1-3HA KEI1-GFP <br />                                                                         (KSY525) cells treated 1% Triton X-100 centrifuged                                                                         prepare supernatant (S) immunoprecipitation anti-HA <br />                                                                         antibody. U, unbound; B, bound materials. Material derived                                                                         10-fold cells loaded sample B samples S                                                                         U. (B) Immunoprecipitation performed cleared lysate <br />                                                                         KRE2-3HA GFP-KEI1 (KSY725) AUR1-3HA KEI1-GFP (KSY721) <br />                                                                         cells analyzed described  <br />  <br />  <br />  <br />                                                                         activity mutant membrane reduced (lanes 4 5). <br />                                                                         Furthermore, reaction carried 37&#194;&#176;C,                                                                         greatly reduced (lanes 8 9). Pre-incubation                                                                         cells 2 h 37&#194;&#176;C collection reduced IPC <br />                                                                         synthesis activity mutant membrane 26.5&#194;&#176;C (lanes 6 <br />                                                                         7), membrane detectable activity 37&#194;&#176;C <br />                                                                         (lanes 10 11).  kei1-1 mutant heat-labile <br />                                                                         IPC synthesis activity. <br /> Figure 5. Isolation kei1-1, temperature-sensitive mutant allele       unclear specific activity IPC KEI1 identification AUR1 strong multicopy suppressor     synthase actually reduced kei1-1 mutant, kei1-1 temperature sensitivity.   KEI1 introduced kei1-1    Aur1-GFP concomitantly decreased mutant CEN plasmid AUR1 introduced kei1-1 mutant 2&#226;&#65533;&#174; plasmid. pRS426 vector. Cells spotted                                                                         kei1-1 membrane, Van1 affected YPD plates 10&#226;&#171;&#187; serial dilution incubated 26.5       (Figure 7A). avoid problem directly assess 37&#194;&#176;C. (B) KEI1/&#226;&#338;&#172;kei1::kanMX4 diploid cells introduced         activity IPC synthase, enzyme isolated immu- vector pRS426, KEI1 CEN plasmid, AUR1 2&#226;&#65533;&#174; plas-           noprecipitation Aur1-3HA anti-HA antibody. mid, sporulated, viability generated tetrads   shown Figure 7B, immunoprecipitates lysate <br /> analyzed. spores single ascus vertically aligned.      AUR1-3HA cells converted C6-NBD-ceramide NBD- <br /> (C) BY4741 kei1-1 mutant (KSY271) streaked SC         IPC dose-dependent manner (lanes 4 &#226;&#8364;&#8220; 6). im- <br /> plates 0.08 &#226;&#65533;&#174;g/ml aureobasidin                        munoprecipitates lysate KRE2-3HA cells pro- <br />                                                                         duced detectable NBD-IPC (lanes 1&#226;&#8364;&#8220;3), confirms <br />                                                                         validity IPC synthase assay  IPC synthesis. used C6-NBD-ceramide substrate                assessed IPC synthase activity isolated IPC synthase, widely used assay IPC              kei1-1 mutant cells. result, showed detectable IPC <br /> synthesis activity yeast microsomal membrane vitro                synthesis activity (lanes 10 &#226;&#8364;&#8220;12), cultivation <br /> (Zhong et al., 1999; Levine et al., 2000; Aeed et al., 2004).           cells IPC synthesis reaction carried Synthesis NBD-IPC completely blocked aureobasi-                permissive temperature, Aur1-3HA pro- <br /> din (Figure 7A, lane 1). cells grown 26.5&#194;&#176;C,             tein kei1-1 sample wild- apparent difference observed IPC synthesis                type sample (lanes 7&#226;&#8364;&#8220;12, immunoblots). kei1-1 IPC syn- <br /> activity 26.5&#194;&#176;C wild-type kei1-1 mutant              thase labile absence membrane lipids <br /> membranes (Figure 7A, lanes 2 3).                  loses activity solubilization immu- <br /> membrane incubated 37&#194;&#176;C reaction,                 noisolation steps. <br />  <br /> Vol. 20, October 15, 2009                                                                                                             4451 <br />  K. Sato et al. <br />  <br />  <br />  <br />  <br /> Figure 7. Kei1 essential activity IPC synthase.   AUR1-3HA&#226;&#8364;&#8220; expressing cells (KSY512 KSY513) grown 26.5&#194;&#176;C incubated indicated temperatures 2 h. Lysate prepared cells, membrane fraction recovered ultracentrifugation. Membrane fractions preincubated indicated temperatures, reaction performed indicated temperatures 1 h. (B) Immunoisolation anti-HA performed cells expressing KRE2-3HA (THY4-2) AUR1-3HA <br /> (KSY525 KSY530) grown 26.5&#194;&#176;C, activity IPC synthase beads 26.5&#194;&#176;C 1 h tested. product NBD-IPC detected TLC LAS-1000plus. proteins beads monitored Western blotting. (C) Immunoisolation anti-HA performed KEI1 AUR1-3HA (KSY771), kei1F103I AUR1-3HA (KSY773), kei1&#226;&#338;&#172;C AUR1-3HA (KSY775) cell lysate, activity IPC synthase determined described B. (D) Immunoprecipitation Aur1-3HA performed cleared lysate KEI1-GFP <br /> AUR1-3HA (KSY792) kei1F103I-GFP AUR1-3HA (KSY794) cells, indicated proteins monitored Western blotting. S, <br /> supernatant; U, unbound; B, bound. Material derived 10-fold cells loaded sample B samples S U. (E) <br /> Immunoprecipitation Aur1-3HA performed cleared lysate GFP-KEI1 AUR1-3HA (KSY799) GFP-kei1F103I AUR1-3HA <br /> (KSY801) cells analyzed described D. <br />  <br />  <br />  <br />    tested mutations kei1-1             apparent growth defect (Supplemental Figure S2A). ex- <br /> responsible loss IPC synthase activity.        amine activity IPC synthase IPC synthase kei1&#226;&#338;&#172;C cells showed significant reduc-           kei1F103I cells significantly affected vivo, assayed <br /> tion IPC synthase activity KEI1 cells           conversion C6-NBD-ceramide NBD-IPC cells (Figure 7C, lanes 1&#226;&#8364;&#8220;3 7&#226;&#8364;&#8220;9), activity IPC syn-          described Levine et al. (2000). result, significant <br /> thase kei1F103I cells significantly decreased (lanes         decrease NDB-IPC production kei1F103I cells ob- <br /> 4 &#226;&#8364;&#8220; 6). result clearly indicates F103I replacement      served (Supplemental Figure S4), suggesting inacti- responsible inactiveness IPC synthase isolated         vation IPC synthase kei1F103I cells occurs kei1-1 cells.                                                         process immunoisolation. <br />    inactivation isolated IPC synthase F103I                Kei1 essential subunit IPC synthase activity, <br /> replacement surprising kei1F103I cells             possible Kei1F103I released Aur1-3HA <br />  <br /> 4452                                                                                                       Molecular Biology Cell <br />                                                                                               Novel Subunit Yeast IPC Synthase <br />  <br />  <br />  <br />  <br /> Figure 8. Aur1-GFP kei1-1 cells deliv- <br /> ered degraded vacuole.   Aur1-GFP levels wild type (lane 1; <br /> KSY512), &#226;&#338;&#172;pep4 (lane 2; KSY571), kei1-1 (lane <br /> 3; KSY513), kei1-1 &#226;&#338;&#172;ubc7 (lanes 4 5; <br /> KSY552, KSY553), kei1-1 &#226;&#338;&#172;doa10 (lanes 6 7; KSY554, KSY561), kei1-1 &#226;&#338;&#172;hrd1 (lanes 8 9; KSY559, KSY560), kei1-1 &#226;&#338;&#172;ubx2 (lanes 10 11; KSY562, KSY563), kei1-1 &#226;&#338;&#172;pep4 <br /> (lane 12; KSY572) cells compared. independent isolates ERAD mutants used cells incubated 26.5&#194;&#176;C. Sim- <br /> ilar results obtained incu- <br /> bation 37&#194;&#176;C 2 h (data shown). (B) localization Aur1-GFP observed fluorescence microscopy left panels. <br /> Nomarski images shown right, merge fluorescence Nomarski im- <br /> ages middle. wild-type (KSY512), <br /> &#226;&#338;&#172;pep4 (KSY571), kei1-1 (KSY513), kei1-1 <br /> &#226;&#338;&#172;pep4 (KSY572) cells incubated 26.5&#194;&#176;C. (C) localization Kre2-3HA KEI1 (KSY790) kei1-1 (KSY784) cells observed fluorescence microscopy. <br /> Cells incubated 26.5&#194;&#176;C 26.5 37&#194;&#176;C 2 h. Bars, 5 &#226;&#65533;&#174;m. <br />  <br />  <br />  immunoisolation, result enzyme inac-          2 h, Aur1-GFP kei1-1 cells decreased <br /> tivation. test possibility, investigated associ-   (lanes 6 7). results suggest degrada- <br /> ation Kei1F103I Aur1-3HA beads. Aur1-3HA         tion Aur1 occurred kei1-1 mutant. immunoprecipitated AUR1-3HA KEI1-GFP cells                possible explanations  explanation AUR1-3HA kei1F103I-GFP cells Figure 7C,             newly produced Aur1 accumulates ER subse- bound proteins analyzed Western blot-           quently degraded ER-associated degradation (ERAD) <br /> ting. expected, significant Kei1-GFP           pathway. explanation Golgi localization bound fraction (Figure 7D, lane 5),          Aur1 unstabilized, Aur1 degraded vacuole. <br /> signal Kei1F103IC-GFP bound fraction hardly        determine possibility actually occurs kei1-1 <br /> detected (Figure 7D, lane 6). Similar result obtained      mutant, deleted genes involved ERAD pathway case GFP-Kei1F103IN (Figure 7E). results dem-        protein degradation vacuole. Deletion genes encod- <br /> onstrate Aur1 does IPC synthase activity      ing Ubc7 (ubiquitin-conjugating enzyme E2; Bays et al., Kei1 essential subunit IPC synthase     2001), Doa10 (ubiquitin ligase E3; Carvalho et al., 2006), Hrd1 activity.                                                 (ubiquitin ligase E3; Bays et al., 2001), Ubx2 (membrane <br />                                                                   protein recruits AAA ATPase Cdc48 substrate pro- Golgi Localization Aur1 Diminished kei1-1            teins; Neuber et al., 2005; Schuberth Buchberger, 2005) <br /> Mutant Aur1 Degraded Vacuole                        did result stabilization Aur1-GFP kei1-1 shown Figure 7A, Aur1-GFP protein             mutant (Figure 8A, lanes 4 &#226;&#8364;&#8220;11). Aur1-GFP restored decreased kei1-1 cells, grew 26.5&#194;&#176;C      wild-type level deletion PEP4, encodes equal Van1               master protease vacuole (Van Den Hazel et al., 1996) <br /> membrane (lanes 2 3). cells grown 37&#194;&#176;C           (Figure 8A, lane 12). result suggests Aur1 unable <br />  <br /> Vol. 20, October 15, 2009                                                                                                   4453 <br />  K. Sato et al. <br />  <br />  <br />                                                                                        Figure 9. C-terminal region Kei1 im- <br />                                                                                        portant stable Golgi localization Kei1                                                                                        Aur1.   PEP4 (&#226;&#171;&#185;) &#226;&#338;&#172;pep4 (&#226;&#171;&#186;) KEI1-GFP <br />                                                                                        (&#226;&#171;&#185;: KSY696, &#226;&#171;&#186;: KSY732), kei1-1-GFP (&#226;&#171;&#185;: KSY698, <br />                                                                                        &#226;&#171;&#186;: KSY780), kei1&#226;&#338;&#172;C-GFP (&#226;&#171;&#185;: KSY694, &#226;&#171;&#186;: <br />                                                                                        KSY730), kei1F103I-GFP (&#226;&#171;&#185;: KSY692, &#226;&#171;&#186;: <br />                                                                                        KSY728) cells incubated 26.5&#194;&#176;C.                                                                                        amounts Kei1F-GFP Kei1C-GFP                                                                                        analyzed Western blotting. Lanes 1&#226;&#8364;&#8220; 6                                                                                        tested gel membrane du- <br />                                                                                        plicated lanes removed. applies <br />                                                                                        lanes 7&#226;&#8364;&#8220;10. (B) PEP4(&#226;&#171;&#185;) &#226;&#338;&#172;pep4(&#226;&#171;&#186;)                                                                                        GFP-KEI1 (&#226;&#171;&#185;: KSY723, &#226;&#171;&#186;: KSY765) GFP- <br />                                                                                        KEI1F103I (&#226;&#171;&#185;: KSY753, &#226;&#171;&#186;: KSY767) cells                                                                                        incubated 26.5&#194;&#176;C. amounts GFP-Kei1F <br />                                                                                        GFP-Kei1N analyzed Western <br />                                                                                        blotting. Lanes 1&#226;&#8364;&#8220; 4 tested gel <br />                                                                                        membrane duplicated lanes  <br />                                                                                        moved. (C) amounts Aur1-3HA                                                                                        KEI1-GFP (KSY771), kei1F103I-GFP (KSY773)                                                                                        kei1&#226;&#338;&#172;C-GFP (KSY775) cells analyzed                                                                                        Western blotting. Duplicate samples                                                                                        tested. (D) GST GST-fusion protein C ter- <br />                                                                                        minus Kei1 (GST-Kei1CT) expressed E. coli <br />                                                                                        purified mixed yeast cell ly- <br />                                                                                        sate. Bound proteins precipitated                                                                                        glutathione-Sepharose detected West- <br />                                                                                        ern blotting indicated antibodies &#226;&#65533;&#163;-COP <br />                                                                                        &#226;&#65533;&#165;-COP. Phosphoglycerate kinase (PGK) <br />                                                                                        detected negative control. <br />  <br />  <br />  stably localize Golgi absence wild-type       kanMX4, amounts Golgi-localized Kei1-1C-GFP Kei1, consequently tends delivered         PEP4 &#226;&#338;&#172;pep4 cells compared. Kei1-1C-GFP graded vacuole. verify Aur1 transported      unable stay Golgi delivered vacuole vacuole kei1-1 cells, observed localization      like Aur1 kei1-1 cells, Kei1-1C-GFP Aur1-GFP kei1-1 cells permissive temperature.        restored deletion PEP4. expected, KEI1 cells, regardless presence absence PEP4,    Kei1-1C-GFP significantly increased &#226;&#338;&#172;pep4 (Figure 9A, <br /> Aur1-GFP displayed punctate Golgi patterns (Figure 8B),       lanes 1 2), wild-type Kei1C-GFP consistent previous observation            affected deletion PEP4 gene (Figure 9A, <br /> showed Aur1-3HA localizes medial-Golgi (Levine et          lanes 5 6). result, conclude Kei1-1C <br /> al., 2000). kei1-1 PEP4 cells, fluorescence Aur1-   itself unable stably localize Golgi delivered <br /> GFP obscure Golgi pattern hardly detected        vacuole. <br /> (Figure 8B); kei1-1 &#226;&#338;&#172;pep4 cells, Aur1-GFP accu-           test F103I substitution &#226;&#338;&#172;C trun- <br /> mulated vacuole (Figure 8B, . contrast,          cation causes loss Golgi localization, checked Kre2-3HA, control medial-Golgi protein shows similar       GFP-Kei1F103IN Kei1&#226;&#338;&#172;CC-GFP PEP4 punctate immunofluorescence pattern, affected          &#226;&#338;&#172;pep4 cells. GFP-Kei1F103IN &#226;&#338;&#172;pep4 cells <br /> kei1-1 temperature (Figure 8C). results,     slightly increased compared PEP4 cells concluded stable Golgi localization Aur1        (Figure 9B, lanes 1 2);  increase compromised kei1-1 cells fraction Aur1 deliv-      observed GFP-Kei1N (Figure 9B, lanes 3 4), ered vacuole degraded Pep4-dependent              suggests wild-type Kei1 constitutively  <br /> manner. worth noting  GFP-fusion              graded Pep4-dependent manner GFP fused proteins mislocalized degraded vacuole,        N terminus. unlikely F103I substi- <br /> fluorescence signal GFP remnants remains detectable        tution affects Golgi localization. contrast, cases (Reggiori Pelham, 2002; Sato Nakano,        Kei1&#226;&#338;&#172;CC-GFP significantly increased 2002; Valdez-Taubas Pelham, 2005).            PEP4 disrupted (Figure 9A, lanes 3 4), case GFP remnants digested.                 Kei1F103IC-GFP Kei1C-GFP did (Figure 9A, <br />                                                                   lanes 5&#226;&#8364;&#8220;10). results indicate C-terminal region <br /> Deletion C Terminus Kei1 Causes                         Kei1 important localization Golgi. obser- <br /> Mislocalization Kei1 Aur1                                  vation Aur1-3HA kei1&#226;&#338;&#172;C cells does Kei1 contribute stable localization Aur1       KEI1 kei1F103I cells (Figure 9C) sup- Golgi? address question, tested           ported importance Kei1 C-terminal region Golgi localization Kei1 unstable    Golgi localization. <br /> kei1-1 mutant. Kei1-1-GFP used experiment. make construct Kei1-1-GFP, nucleotide sequence         Cytosolic C-Terminal Peptide Kei1 Interact manipulated F103I, Q193K, K194T replace-          Coat Protein (COP Coatomer <br /> ments introduced Kei1 sequence, GFP           Kex2 exerts protease activity lumen Golgi; <br /> directly fused 194Thr residue Kei1. Kei1-1-GFP       Kex2 recognition site Kei1, 135Arg resi- <br /> produced cells genomic KEI1 replaced            locate lumen.  <br /> 4454                                                                                                   Molecular Biology Cell <br />                                                                                                 Novel Subunit Yeast IPC Synthase <br />  <br />  hydrophobic segment 135Arg C termi-               cleavage Kei1 Kex2 does nus, C terminus Kei1 likely exposed    biologically important, allowed investigate cytoplasm. cases known, cytoplasmic             localization IPC synthase  Kei1 Golgi <br /> C-terminal peptide ER Golgi membrane proteins           fractions cleaved Kex2 protease resides <br /> interacts coatomer, responsible retrograde       late Golgi compartment, Kei1 trafficking secretory pathway. example, dil-        medial-Golgi (Figure 4). suggests Kei1 <br /> ysine motif KKXX KXKXX binds coatomer directly           temporarily transported late Golgi supports incorporation proteins motif        cleaved Kex2. Kei1 efficiently transported retro- COPI vesicle (Jackson et al., 1990; Cosson Letour-         grade medial-Golgi. Kei1C-GFP hardly <br /> neur, 1994). Furthermore, dilysine motif does         detected Sed5-rich fractions Golgi compart- exist Rer1, Emp24, Vrg4, relatively basic          ments fractionated sucrose density gradient centrif- <br /> C-terminal tails interact coatomer important      ugation (Figure 4A), Kei1 likely recycle Golgi localization (Belden Barlowe, 2001; Sato et        medial- late Golgi COPI-dependent manner. al., 2001; Abe et al., 2004). hypothesized Kei1       idea consistent previous report Aur1 does <br /> interacts coatomer C-terminal tail like     recycle ER secretion block experiments <br /> proteins, tested GST pull assay. pep-         (Levine et al., 2000). mammalian cells, <span id='am-31' about='obo:IMR_0001361' typeof='owl:Thing obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001359 obo:IMR_0001383 obo:IMR_0000001 obo:IMR_0001362'><span id='am-32' property="oboInOwl:hasDbXref" content="KEGG:C00550" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:id" content="IMR:0001361" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="sphingomyelin" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasDbXref" content="CHEBI:17636" datatype="xsd:string"></span>sphingomyelin</span> <br /> tide 176Gln 221Glu Kei1 fused C termi-       (SM) synthase 1, produces SM newly synthe- <br /> nus GST. fusion protein produced E. coli         sized ceramide, localizes trans-Golgi network <br /> purified glutathione-Sepharose affinity beads.            (Huitema et al., 2004). Ceramide transfer protein (CERT) <br /> beads mixed yeast cell lysate, proteins          directly transfers newly synthesized ceramide ER bound beads analyzed. shown Figure          site SM synthesis trans-Golgi network <br /> 9D, coatomers, &#226;&#65533;&#163;-COP Ret1 &#226;&#65533;&#165;-COP              (Hanada et al., 2003). reported ceramide <br /> Sec21, bound C-terminal peptide Kei1. Phospho-           transferred ER Golgi vesicular glycerate kinase, negative control, detected.       nonvesicular transport yeast (Funato Riezman, 2001), <br /> result suggests Kei1 helps medial-Golgi localization      possible unidentified functional homologue of IPC synthase COPI vesicle-dependent manner.                CERT carries ceramide ER medial-Golgi. <br />                                                                     protein homologous CERT sequence                                                                    far. <br /> DISCUSSION                                                            identified GDA1, PSD1, SFH1 multicopy sup- <br />                                                                    pressors kei1-1 mutant. suppressor activities <br /> Genetic biochemical approaches using temperature-sen-          obviously lower AUR1 reproduc- <br /> sitive mutants provide effective clues elucidate bio-       ible significant. Currently, mechanism sup- <br /> logical roles unknown essential proteins, reported        pression clear, sphingolipid metabolism previously study Pga1, novel subunit GPI-           involved. GDA1 encodes GDPase converts <br /> mannosyltransferase II (Sato et al., 2007). kei1-1 mutant,     guanosine diphosphate (GDP) guanosine monophosphate obtained screening temperature-sen-           mannose transferred substrate mannosyl- <br /> sitive mutants KEI1, F103I substitution &#226;&#338;&#172;C            transferases Golgi, conversion required truncation, required temperature sen-         transport cytosolic GDP-mannose Golgi lu- <br /> sitivity. F103I substitution silent cell,   men (Abeijon et al., 1993; Berninsone et al., 1994). sup- mutant IPC synthase activity supply          pose multicopy expression GDA1 activate <br /> IPC cell growth.  Kei1F103I released           sphingolipid synthetic pathway Golgi increas- <br /> Aur1 immunoisolation abolishes IPC synthase             ing supply GDP-mannose, substrate MIPC <br /> activity. clearly shows Aur1 unable          synthase. PSD1 encodes <span id='am-16' about='obo:IMR_0001358' typeof='owl:Thing obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-17' property="oboInOwl:hasDbXref" content="KEGG:C02737" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasExactSynonym" content="O-Phosphatidyl-L-serine" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="phosphatidylserine" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasAlternativeId" content="IMR:0200250" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasDbXref" content="CHEBI:18303" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:id" content="IMR:0001358" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="O-Phosphatidyl-L-serine" datatype="xsd:string"></span>phosphatidylserine</span> decarboxylase <br /> catalyze IPC synthesis. &#226;&#338;&#172;C truncation disturbs Golgi           mitochondrial inner membrane, converts phos- <br /> localization causes degradation enzyme           phatidylserine phosphatidylethanolamine (Clancey et al., <br /> vacuole. Binding C-terminal peptide coatomer sug-        1993). relationship Psd1 Kei1 gests Kei1 role incorporate IPC synthase        reported, possible mitochondrial lipid com- COPI vesicles recycling. F103I &#226;&#338;&#172;C         position affects lipid homeostasis Golgi different effects Kei1 protein, combined, syn-         reduction IPC impairs function mitochondria ergistically cause temperature sensitivity. conclude       Psd1 repairs  Sfh1 homologues lipid <br /> Aur1 requires Kei1 IPC synthase activity cor-         transfer protein Sec14 S. cerevisiae highest <br /> rect localization Golgi.                                    similarity lowest functional relationship Sec14. <br />    finding Kex2 cleaves Kei1 (Figure 3) led          Sfh1 lacks lipid transfer activity vitro; <br /> hypothesize IPC synthase activity regulated         molecular function Sfh1 vivo unclear proteolytic processing.  contrary           (Li et al., 2000).  multicopy suppressor activity <br /> apparent difference activity, sub-       SFH1 indicate Sfh1 actually involved lipid <br /> unit interaction, localization IPC synthase          metabolism. Previous investigations using DNA microarray <br /> unpublished data).  evidence            analysis revealed SFH1 gene expression signifi- Kex2 cleavage regulates IPC synthesis.           cantly enhanced various stress conditions (Griac, 2007). <br /> Kei1 sequence highly homologous fungal counter-          Considering number studies demonstrated parts, hydrophilic region 135Arg cleavage         sphingolipids important stress responses, Sfh1 site conserved (Figure 2A). Arginine       regulate genes related sphingolipid metabolism. Al- <br /> Candida glabrata, basic residue Vanderwal-      hypothesis examined, observa- <br /> tozyma polyspora. suggest generation Kex2 cleav-        tion Sfh1 localization nucleus Golgi (Schnabl et <br /> age site S. cerevisiae Kei1 accidental event      al., 2003) suggests possible role Sfh1 links lipid <br /> evolution specific advantages disadvantages          composition Golgi membrane regulation IPC synthesis.                                                     gene expression. <br />  <br />    Concerning role sphingolipids stress                        <br /> sponse, interesting findings reported experiments                     <br /> ing &#226;&#338;&#172;lcb1 slc1-1 double mutant sphingolipids produces mannosylated phosphatidylinositol deriva-                     <br /> tives containing C26 fatty acid (Dickson et al., 1990; Patton            <br /> et al., 1992; Lester et al., 1993). mutant grow  <br />                                                                                 <br /> mally adequate growth conditions, growth                           <br /> significantly inhibited high temperature low high                   <br /> pH, indicating cells adapt immoderate <br />                                                                                <br /> environments sphingolipids. results demon-                        <br /> strate ceramides key mediator signaling            <br /> stress response. IPC synthase activity define balance                   ceramide complex sphingolipids;                     regulated stringently response stimuli caused                        <br /> intracellular environmental changes. Kei1 responsible                  localization activity IPC synthase,                     ideal feature regulatory subunit. Inter-                     <br /> estingly, observed Kei1 signifi-                    <br /> cantly increased kei1-1 cells compared wild-type cells                    <br />  unpublished data), suggesting cells regulate                        <br /> KEI1 response decreasing amounts IPC                          <br /> increase ceramide. hypothesis currently                           <br /> investigation.                                                                    <br />    tagging 3HA C terminus Aur1 affected                        ratio Kei1C Kei1F (Figure 6), possible Aur1                  responsible transport Kei1.  pre-                  <br /> liminary data Kei1 accumulates ER                             <br /> reduction Aur1 promoter shut experiments, sug- <br /> gesting exit IPC synthase ER Golgi              <br /> requires Aur1&#226;&#8364;&#8220;Kei1 complex formation.                         <br /> ing investigate cells regulate production, <br /> complex formation, localization Aur1 Kei1.                             <br />   <br /> </body></html>